Chronic active hepatitis (CAH) patients exhibit reduced suppressor T lymphocyte function. Thymosin fraction 5 treatment in vitro restored this function, indicating potential therapeutic benefits for immune modulation in CAH.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: